文献速递心律失常心力衰竭与心肌病瓣膜病与结构性心脏病

心律失常性心肌病中的猝死与左心室受累

Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.
PubMed 文献 · Circulation · 2019-01-01

该研究分析1994至2018年5205例连续猝死病例,其中202例(4%)经尸检诊断为心律失常性心肌病(ACM)。多数死者生前无症状,左心室组织病理受累占87%,当前Task Force标准可能漏诊双心室型ACM。

要点

  • ACM相关猝死以男性为主,多数生前无心脏症状。
  • 左心室病理受累在尸检确诊ACM中占87%。
  • 现有Task Force标准可能无法在生前诊断双心室型ACM。

核心结论

  • ACM相关猝死主要影响男性,多在运动时发生且生前无心脏症状,左心室受累在尸检确诊者中极常见。

研究设计与样本

  • 研究连续纳入1994至2018年转诊至国家级心脏病理中心的5205例猝死病例,经专家病理评估后202例(4%)诊断为ACM。
  • 对202例ACM死者记录既往症状、病史、死亡情形及竞技运动参与情况,其中24例(12%)进行死后基因检测。

主要发现

  • 202例ACM死者年龄35.4±13.2岁,男性占82%,157例(78%)无既往心脏症状。
  • 41例(20%)为竞技运动参与者,男性体力活动时死亡调整比值比4.58(95%CI 1.54-13.68,P=0.006),竞技运动员较非运动员比值比16.62(95%CI 5.39-51.24,P<0.001)。
  • 左心室组织病理受累176/202(87%),孤立右心室病变13%,孤立左心室病变17%,双心室受累70%。
  • 全心中纤维脂肪浸润最常见于左心室后基底壁(68%)和前侧壁(58%)。
  • 死后基因检测24例中6例(25%)发现ACM相关基因致病性变异。

关键数值与推荐

  • 生前诊断为扩张型心肌病的死者均不符合2010年Task Force definite标准。
  • 心脏宏观外观正常者40/202(20%)。

临床怎么用

  • 对运动相关猝死且生前无症状者应警惕ACM,尸检需仔细评估左心室。
  • 当前Task Force标准可能漏诊双心室型ACM,生前诊断需结合更多信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Arrhythmogenic cardiomyopathy (ACM) is an inherited heart muscle disorder characterized by myocardial fibrofatty replacement and an increased risk of sudden cardiac death (SCD). Originally described as a right ventricular disease, ACM is increasingly recognized as a biventricular entity. We evaluated pathological, genetic, and clinical associations in a large SCD cohort. METHODS: We investigated 5205 consecutive cases of SCD referred to a national cardiac pathology center between 1994 and 2018. Hearts and tissue blocks were examined by expert cardiac pathologists. After comprehensive histological evaluation, 202 cases (4%) were diagnosed with ACM. Of these, 15 (7%) were diagnosed antemortem with dilated cardiomyopathy (n=8) or ACM (n=7). Previous symptoms, medical history, circumstances of death, and participation in competitive sport were recorded. Postmortem genetic testing was undertaken in 24 of 202 (12%). Rare genetic variants were classified according to American College of Medical Genetics and Genomics criteria. RESULTS: Of 202 ACM decedents (35.4±13.2 years; 82% male), no previous cardiac symptoms were reported in 157 (78%). Forty-one decedents (41/202; 20%) had been participants in competitive sport. The adjusted odds of dying during physical exertion were higher in men than in women (odds ratio, 4.58; 95% CI, 1.54-13.68; P=0.006) and in competitive athletes in comparison with nonathletes (odds ratio, 16.62; 95% CI, 5.39-51.24; P<0.001). None of the decedents with an antemortem diagnosis of dilated cardiomyopathy fulfilled definite 2010 Task Force criteria. The macroscopic appearance of the heart was normal in 40 of 202 (20%) cases. There was left ventricular histopathologic involvement in 176 of 202 (87%). Isolated right ventricular disease was seen in 13%, isolated left ventricular disease in 17%, and biventricular involvement in 70%. Among whole hearts, the most common areas of fibrofatty infiltration were the left ventricular posterobasal (68%) and anterolateral walls (58%). Postmortem genetic testing yielded pathogenic variants in ACM-related genes in 6 of 24 (25%) decedents. CONCLUSIONS: SCD attributable to ACM affects men predominantly, most commonly occurring during exertion in athletic individuals in the absence of previous reported cardiac symptoms. Left ventricular involvement is observed in the vast majority of SCD cases diagnosed with ACM at autopsy. Current Task Force criteria may fail to diagnose biventricular ACM before death.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Miles C, Finocchiaro G, Papadakis M, et al. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy. Circulation. 2019. PMID: 30700137. doi:10.1161/CIRCULATIONAHA.118.037230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。